未登录

印

印悦 (Yue Yin)

北京大学

H指数:31

被引数:3,326

个人简介

"印悦，北京理工大学预聘助理教授（特别副研究员）。多年来从事生物医用材料，药物递送系统的设计、构建和其在免疫治疗方面的应用等研究工作。目前，以第一/共同第一作者在Nature Communications, Research, Nano Letters, ACS Nano, Biomaterials等杂志发表SCI论文12篇，主持国家自然科学基金青年项目1项。教育培训经历 2014.3-2019.2, 成均馆大学, 制药工程系, 博士 2009.8-2013.6, 吉林大学, 药学系, 学士工作经历 2021.12-至今, 北京理工大学，医学技术学院, 特别副研究员/助理教授 2019.7-2021.12, 国家纳米科学中心，中国科学院纳米生物效应与安全性重点实验室, 特别研究助理 2019.2-2019.7, 成均馆大学，医用高分子研究中心, 博士后"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ganoderic acid A accelerates osteoporotic fracture healing by promoting osteogenic differentiation via estrogen receptor alpha binding

灵芝酸A通过促进雌激素受体α结合促进成骨分化，加速骨质疏松性骨折愈合

Journal of Orthopaedic Translation

IF7.8

2026-07-230

OAAI

Clinicopathological and Prognostic Characteristics of Gastric-Type Endocervical Adenocarcinoma: A Nested Case–Control Study

胃型宫颈内膜腺癌的临床病理及预后特征：一项巢式病例对照研究

IF4.4

2026-04-040

OAAI

Microneedle patch-involved local therapy synergized with immune checkpoint inhibitor for pre- and post-operative cancer treatment

微针贴片参与的局部疗法与免疫检查点抑制剂协同用于术前和术后癌症治疗

JOURNAL OF CONTROLLED RELEASE

IF11.5

2025-03-012

PRE

Development and validation of the Chinese patient-centered integrated care scale

中文患者中心整合护理量表的研制与验证

health services research

IF3

2024-12-310

OA

Bioorthogonal Chemistry-Guided Inhalable Nanoprodrug to Circumvent Cisplatin Resistance in Orthotopic Nonsmall Cell Lung Cancer

生物正交化学指导的可吸入纳米前药可避免原位非小细胞肺癌的顺铂耐药性

IF16

2024-11-090

PRE

Bacterial outer membrane vesicles-clothed nanoparticles delivered by live macrophages for potentiating antitumor photoimmunotherapy

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-11-011

PRE

Micro/nano system-mediated local treatment in conjunction with immune checkpoint inhibitor against advanced-Stage malignant melanoma

微/纳米系统介导的局部治疗联合免疫检查点抑制剂治疗晚期恶性黑色素瘤

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-10-011

PRE

Acacetin protects against acute lung injury by upregulating SIRT1/ NF-κB pathway

刺槐素通过上调SIRT1/nf-κb通路对急性肺损伤的保护作用

IF3.6

2024-09-011

OAAI

Size-switchable and dual-targeting nanomedicine for cancer chemoimmunotherapy by potentiating deep tumor penetration and antitumor immunity

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-08-013

PRE

Photoresponsive Multirole Nanoweapon Camouflaged by Hybrid Cell Membrane Vesicles for Efficient Antibacterial Therapy of Pseudomonas aeruginosa-Infected Pneumonia and Wound

ADVANCED SCIENCE

IF14.1

2024-07-153

OA

Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer

CLINICA CHIMICA ACTA

IF2.9

2024-07-010

PRE

Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy

IF9.1

2024-05-218

PRE

Blood-Brain Barrier-Penetrating and Lesion-Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy

协同缺血性卒中治疗的病理生理学特征启发的血脑屏障穿透和病灶靶向纳米平台

ADVANCED MATERIALS

IF26.8

2024-02-2216

PRE

Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages

化学免疫治疗纳米凝胶通过重编程肿瘤相关巨噬细胞用于恶性黑色素瘤的术前和术后治疗

IF9.1

2024-01-2511

PRE

O-GlcNAcylation of TLR4 inhibits osteogenic differentiation of periodontal ligament stem cells

TLR4的o-glcnac修饰抑制牙周膜干细胞的成骨分化

JOURNAL OF PERIODONTAL RESEARCH

IF3.4

2023-10-105

PRE

Extracellular Vesicles-Derived Hybrid Nanoplatforms for Amplified CD47 Blockade-Based Cancer Immunotherapy

细胞外囊泡衍生的混合纳米平台用于基于扩增CD47阻断的癌症免疫治疗

ADVANCED MATERIALS

IF26.8

2023-07-1339

PRE

Human RNA Modifications Disease Database (HRMDD): A web resource for the molecular and clinical landscape of RNA modifications in human diseases

GENES & DISEASES

IF9.4

2023-07-011

OAAI

Nutrient-sensing nanoprotoplast augments tumor accumulation and immune response with short-term starvation

IF10.9

2023-04-013

PRE

Physiological Responses of Methanosarcina barkeri under Ammonia Stress at the Molecular Level: The Unignorable Lipid Reprogramming

ENVIRONMENTAL SCIENCE & TECHNOLOGY

IF11.3

2023-02-2318

PRE

Highly Prolonged Release of the Cancer Vaccine and Immunomodulator via a Two-Layer Biodegradable Microneedle for Prophylactic Treatment of Metastatic Cancer

BIOMACROMOLECULES

IF5.4

2023-02-2116

PRE